AB

Anurag Bhati

Active Director Director DIN 07429930
DIN 07429930 First appointment May 2016 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Anurag Bhati

Data last updated:

Anurag Bhati is a Director at Suave Pharmaceuticals Private Limited (since 2016). The company operates in Electrnoics. Suave Pharmaceuticals Private Limited reported revenue of ₹3.9 Lakh (FY 2019).

DIN 07429930
Primary Designation Director
Industry Electrnoics
First Appointment 14 May 2016
Oldest Company Age 10 yrs
Largest company Suave Pharmaceuticals Private Limited · ₹3.9 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 May 20162016₹3.9 Lakh (FY 2019)Active

Board colleagues of Anurag Bhati

NameDINCompanyDesignation
Ratan Kumar Dwivedi07429966Suave Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Suave Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anurag Bhati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anurag Bhati

Anurag Bhati currently holds 1 directorship: Suave Pharmaceuticals Private Limited (Director, since 14 May 2016, revenue ₹3.9 Lakh (FY 2019)).

Anurag Bhati was first appointed on 14 May 2016 as Director at Suave Pharmaceuticals Private Limited.

The current boards of Anurag Bhati's companies include Ratan Kumar Dwivedi (Suave Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available